Summary
N-alkylated and N, N-dialkylated cis-(+)-(1 S, 2 R)-5-methoxy-1-methyl-2-aminotetralins were tested for central dopamine receptor antagonism usingin vivo biochemical and behavioral models in rats. The di-methyl analogue showed a profile similar to classical dopamine receptor antagonists. It produced a marked hypomotility including catalepsy and a pronounced increase in dopamine synthesis rate. This compound also displaced DiPr-5, 6-ADTN from striatal binding sites and antagonized the hyperactivity induced by the ligand. In contrast, the mono-propyl analogue increased locomotor activity and dopamine synthesis rate over a wide dose range. This compound failed to antagonize the hyperactivity induced by DiPr-5, 6-ADTN and to displace thisin-vivo binding ligand. Thus, the mono-propyl analogue appears to lack postsynaptic dopamine receptor antagonistic properties; it seems to produce its effects via a selective dopamine autoreceptor antagonism. The di-ethyl and di-propyl, but not the dibutyl, analogues were also active in the models used. Whereas the di-ethyl compound shows a profile similar to classical dopamine receptor blockers, the di-propyl compound appears to act preferentially on autoreceptors.
Similar content being viewed by others
References
Carlsson, A.: Mechanism of action of neuroleptic drugs. In: Psychopharmacology: A Generation of Progress (Lipton, M. A., DiMascio, A., Killam, K. F., eds.), pp. 1057–1070. New York: Raven Press. 1978.
Carlsson, A., Löfberg, L.:In vivo displacement by 3-PPP enantiomers of N, N-Dipropyl-5, 6-ADTN from dopamine receptor binding sites in rat striatum. J. Neural Transm.64, 173–185 (1985).
Dunnett, C. W.: A multiple comparison procedure for comparing several treatments with a control. J. Am. Statis. Ass.50, 1096–1121 (1955).
Dunnett, C. W.: New tables for multiple comparisons with a control. Biometrics20, 482–491 (1964).
Feenstra, M. G. P., Rollema, H., Mulder, T. B. A., Westerink, B. H. C., Horn, A. S.:In vivo dopamine receptor binding studies with a non-radioactively labelled agonist, di-propyl-5,6-ADTN. Life Sci.32, 1313–1323 (1983 a).
Feenstra, M. G. P., Rollema, H., Mulder, T. B. A., De Vries, J. B., Horn, A. S.:In vivo dopamine receptor agonist binding in rat brain: relation with pharmacological effects. Eur. J. Pharmacol.90, 433–436 (1983 b).
Hacksell, U., Svensson, U., Nilsson, J. L. G., Hjorth, S., Carlsson, A., Wikström, H., Lindberg, P., Sanchez, D.: N-alkylated 2-aminotetralins: central dopamine-receptor stimulating activity. J. Med. Chem.22, 1469–1475 (1979).
Johansson, A. M., Arvidsson, L.-E., Hacksell, U., Nilsson, J. L. G., Svensson, K., Hjorth, S., Clark, D., Carlsson, A., Sanchez, D., Andersson, B., Wikström, H.: Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors. J. Med. Chem.28, 1049–1054 (1985).
McDermed, J. D., McKenzie, G. M., Phillips, A. P.: Synthesis and pharmacology of some 2-aminotetralins. Dopamine receptor agonists. J. Med. Chem.18, 362–367 (1975).
Shore, P. A.: Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron. J. Pharm. Pharmacol.28, 855–857 (1976).
Shum, A., Sole, M. J., van Loon, G. R.: Simultaneous measurement of 5-hydroxytryptophan and 1-dihydroxyphenylalanine by high-performance liquid chromatography with electrochemical detection. Measurement of serotonin and catecholamine turnover in discrete brain regions. J. Chromatogr.228, 123–130 (1982).
Svensson, K., Hjorth, S., Clark, D., Carlsson, A., Wikström, H., Andersson, B., Sanchez, D., Johansson, A. M., Arvidsson, L.-E., Hacksell, U., Nilsson, J. L. G.: (+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors. J. Neural Transm.65, 1–27 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Svensson, K., Carlsson, A., Johansson, A.M. et al. A homologous series of N-alkylated cis-(+)-(1 S, 2 R)-5-methoxy-1-methyl-2-aminotetralins: Central dopamine receptor antagonists showing profiles ranging from classical antagonism to selectivity for autoreceptors. J. Neural Transmission 65, 29–38 (1986). https://doi.org/10.1007/BF01249609
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01249609